Daniel Griffin

Dr. Daniel Griffin, an infectious disease clinician and weekly commentator, discusses intriguing findings, including how the shingles vaccine may lower dementia rates. He critiques FDA claims linking COVID vaccines to children's deaths, updates on the measles epidemic, and shares insights on rising respiratory viruses like RSV and H3 influenza. Griffin also highlights the benefits of one-dose HPV vaccination and addresses long COVID symptoms, including neurodegenerative changes and effective treatments like celiac plexus blocks.

Daniel Griffin, infectious disease clinician who provides weekly clinical updates, tackles rising measles outbreaks and the hidden costs of declining MMR coverage. He covers H5N1 in California elephant seals, current influenza strain choices, RSV and testing trends, COVID hospital data and pediatric vaccine access, plus the latest on long COVID trials and how to counter misinformation.

Dr. Daniel Griffin, an infectious disease clinician and researcher, offers a wealth of insights on viral infections. He discusses concerning links between in utero SARS-CoV-2 exposure and neurodevelopmental issues in children. The benefits of HPV vaccination in enhancing viral clearance are explored, alongside the troubling rise in measles cases among vaccinated healthcare workers. He also highlights the effectiveness of Paxlovid in reducing COVID-related hospitalizations and the role of vaccination in preventing long COVID in adolescents, making a strong case for science in healthcare.

Daniel Griffin, infectious diseases clinician who gives weekly clinical updates, walks through recent shifts in vaccine reviews and public-health leadership. He covers measles outbreaks and immune amnesia, RSV and cardiac risks, current influenza trends, SARS-CoV-2 impacts on fertility and diabetes risk, gaps in antiviral use, and practical travel and vaccination advice.

Dr. Daniel Griffin, a physician and infectious disease specialist, provides insight into the current landscape of respiratory viruses and vaccine-preventable illnesses. He discusses the alarming rise in whooping cough and low tetanus vaccination rates. Griffin analyzes the surge in flu cases, particularly in New York, and shares recent statistics on measles and RSV. He highlights public health challenges, urges action against anti-science sentiments, and offers guidance on navigating long COVID. Tune in for an engaging blend of clinical updates and urgent public health messages.

Dr. Daniel Griffin, a physician and infectious diseases expert, joins Vincent Racaniello for an informative discussion. They express concerns over RFK's impact on vaccine policies, stressing the risks of neglecting immunization practices. The duo reviews alarming data on RSV, influenza, and COVID-19, along with recent advancements in monoclonal antibody treatments. They also explore emerging long COVID therapies and the importance of maintaining global vaccination efforts while addressing vaccine hesitancy. A call to action for scientific integrity resonates throughout the conversation.

Daniel Griffin, an infectious disease clinician who does weekly clinical updates, covers bird flu die-offs, the FDA’s new adverse event system, and court rulings affecting immunization policy. He reviews measles outbreaks and trackers, unusual RSV timing and vaccine expansion, influenza and COVID trends, links between respiratory infections and cancer, and resources for long COVID and public advocacy.

Daniel Griffin, an infectious disease clinician who gives weekly clinical updates on respiratory viruses and patient care. He digs into global polio circulation and vaccination advice. Measles outbreaks and vaccination gaps in the US are highlighted. Discussions include zoonotic spillover without prior adaptation, RSV and flu trends, wastewater surveillance, Paxlovid access, and the shrinking of long COVID clinics.

Daniel Griffin, infectious diseases clinician and researcher who provides regular clinical updates, tackles vaccine policy battles and outbreak responses. He covers the Pakistan vaccine-derived polio situation, rising measles and Candida auris surveillance, and current RSV, flu, and COVID trends. He also discusses pregnancy vaccination timing, travel health tips, and practical access to treatments like Paxlovid and baloxavir.

Dr. Daniel Griffin, an infectious disease clinician and researcher, dives into pressing viral concerns, from a new high path influenza case in Wisconsin to the Marburg outbreak in Ethiopia. He highlights the alarming rise of measles cases across North America and discusses the effectiveness of current influenza antivirals. Key insights include the higher mortality rates linked to COVID-19 compared to influenza, and the promising data on nirsevimab for RSV prevention in infants. The importance of vaccination remains a recurring theme throughout their insightful chat.